8 research outputs found
Plasma high density lipoprotein small subclass is reduced in Alzheimer’s disease patients and correlates with cognitive performance
Background: The link between cholesterol and Alzheimer’s disease (AD) has received much attention, as evidence suggests high levels of cholesterol might be an AD risk factor. The carriage of cholesterol and lipids through the body is mediated via lipoproteins, some of which, particularly apolipoprotein E (ApoE), are intimately linked with AD. In humans, high density lipoprotein (HDL) is regarded as a “good” lipid complex due to its ability to enable clearance of excess cholesterol via ‘cholesterol reverse transport’, although its activities in the pathogenesis of AD are poorly understood. There are several subclasses of HDL; these range from the newly formed small HDL, to much larger HDL. Objective: We examined the major subclasses of HDL in healthy controls, mild cognitively impaired, and AD patients who were not taking statins to determine whether there were HDL profile differences between the groups, and whether HDL subclass levels correlated with plasma amyloid-β (Aβ) levels or brain Aβ deposition. Methods: Samples from AIBL cohort were used in this study. HDL subclass levels were assessed by Lipoprint while Aβ1–42 levels were assessed by ELISA. Brain Aβ deposition was assessed by PET scan. Statistical analysis was performed using parametric and non-parametric tests. Results: We found that small HDL subclass is reduced in AD patients and it correlates with cognitive performance while plasma Aβ concentrations do not correlate with lipid profile or HDL subfraction levels. Conclusion: Our data indicate that AD patients exhibit altered plasma HDL profile and that HDL subclasses correlate with cognitive performances
Direct analysis - no sample preparation - of bioavailable cortisol in human plasma by weak affinity chromatography (WAC)
10.1016/j.jchromb.2017.07.035JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES1061438-44
Synthetic Enzymology and the Fountain of Youth: Repurposing Biology for Longevity
10.1021/acsomega.8b01620ACS OMEGA3911050-1106
Synthetic Enzymology and the Fountain of Youth: Repurposing Biology for Longevity
Caloric
restriction (CR) is an intervention that can increase maximal
lifespan in organisms, but its application to humans remains challenging.
A more feasible approach to achieve lifespan extension is to develop
CR mimetics that target biochemical pathways affected by CR. Recent
studies in the engineering and structural characterization of polyketide
synthases (PKSs) have facilitated their use as biocatalysts to produce
novel polyketides. Here, we show that by establishing a combinatorial
biosynthetic route in Escherichia coli and exploring the substrate promiscuity of a mutant PKS from alfalfa,
413 potential anti-ageing polyketides were biosynthesized. In this
approach, novel acyl-coenzyme A (CoA) precursors generated by promiscuous
acid-CoA ligases were utilized by PKS to generate polyketides which
were then fed to Caenorhabditis elegans to study their potential efficacy in lifespan extension. It was
found that CR mimetics like resveratrol can counter the age-associated
decline in mitochondrial function and increase the lifespan of C. elegans. Using the mitochondrial respiration profile
of C. elegans supplemented for 8 days
with 50 μM resveratrol as a blueprint, we can screen our novel
polyketides for potential CR mimetics with improved potency. This
study highlights the utility of synthetic enzymology in the development
of novel anti-ageing therapeutics
Host/malassezia interaction: A quantitative, non-invasive method profiling oxylipin production associates human skin eicosanoids with malassezia
10.3390/metabo11100700Metabolites111070
Direct analysis – no sample preparation – of bioavailable cortisol in human plasma by weak affinity chromatography (WAC)
Functional organization of the yeast proteome by systematic analysis of protein complexes.
Most cellular processes are carried out by multiprotein complexes. The identification and analysis of their components provides insight into how the ensemble of expressed proteins (proteome) is organized into functional units. We used tandem-affinity purification (TAP) and mass spectrometry in a large-scale approach to characterize multiprotein complexes in Saccharomyces cerevisiae. We processed 1,739 genes, including 1,143 human orthologues of relevance to human biology, and purified 589 protein assemblies. Bioinformatic analysis of these assemblies defined 232 distinct multiprotein complexes and proposed new cellular roles for 344 proteins, including 231 proteins with no previous functional annotation. Comparison of yeast and human complexes showed that conservation across species extends from single proteins to their molecular environment. Our analysis provides an outline of the eukaryotic proteome as a network of protein complexes at a level of organization beyond binary interactions. This higher-order map contains fundamental biological information and offers the context for a more reasoned and informed approach to drug discovery